Sequencing Stories

Amplicon sequencing is based on NGS technology. The ultra-deep sequencing of amplicons (PCR products) allows efficient variant identification and characterization.

https://www.capitalbiotechnology.com/products/individualized-medication-guidance-for-gastrointestinal-cancer/ This test detects 84 genes related to gastrointestinal canc...

According to a new market research report "Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Ser...

Currently, the most commonly used technique for protein sequence analysis is mass spectrometry. Mass spectrometry is a highly efficient method for the accurate mass dete...

Data Bridge Market Research analyzes that the North America next generation sequencing (NGS) market, which was USD 3489.40 million in 2022, will reach USD 15615.61 milli...

https://www.capitalbiotechnology.com/transcriptome-sequencing/ RNA transcriptome can change with the external environment, which is different from the genome. Since the...

https://www.capitalbiotechnology.com/microbiome-sequencing/ Microorganisms exist in the human body, plants, soil, sea, and other environments. The collection of all micr...

Creative Biolabs is glad to show a series of unique de novo antibody sequencing services for research, diagnostic, and therapeutic industries. To overcome the current dr...

Global Next Generation Sequencing Market which was worth USD 3.63 billion by the end of 2018 is poised to reach USD 8.54 billion by 2023 at a CAGR of 18.66%.

High-throughput sequencing otherwise known as next-generation sequencing is revolutionizing microbiology and medicine with the continuous development of sequencing techn...